4 / 21
Page 34
Notes:
allied
academies
Journal of Timely Topics in Clinical Immunology | Volume 2
July 26-28, 2018 | Moscow, Russia
Immunology
11
th
Annual Congress on
Strategies to avoid lack of response of Immunobiological drugs delivered subcutaneously
Patricia Fabrini, Marco Araujo, Luísa Coutinho Teixeira
and
Marina Rodrigues Costa Lages
Santhè Clinic, Brazil
T
he present work aims to highlight different ways to prevent
diminished or lack of response of immunobiological drugs
delivered subcutaneously, therefore reducing the burden of
treatment with immunobiological drugs for both patients and
healthcare system. Etanercept is an immunobiological drug
with anti-TNF action, applied subcutaneously, which is indicated
in cases of psoriasis refractory to other treatments. The present
study shows a possible lack of response to the treatment
after consecutive applications in the same anatomical site.
Speaker Biography
Patrícia Fabrini helds an infusional center in Belo Horizonte, Minas Gerais, Brazil. She
also works as a dermatologist in Santa Casa, a great hospital in the city.She is nowadays
responsible for the infusion of many of the patients diagnosed with immunomediated
diseases, like Psoriaisis, Arthritis, Crohn’s disease and Ankyloosing Spondyhlitis
where patients with psoriasis and arthritis receive immunobiological treatment.
e:
saudesanthe@hotmail.com